| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | Oct 9, 2025 | ITUS Capital | - | - | CUB.NS, DRREDDY.NS, ERIS.NS, HDFCAMC.NS, HDFCBANK.NS, HDFCLIFE.NS, HINDCOPPER.NS, HINDZINC.NS, ICICIBANK.NS, ICICIGI.NS, IGI.NS, PAYTM.NS, PBFINTECH.NS, PIRAMALP.NS, SBIN.NS, SRF.NS, SWIGGY.NS, TATASTEEL.NS, TITAN.NS, VEDL.NS | Banking, Chemicals, consumption, earnings, growth, healthcare, India, Platforms | Platform businesses are entering a favorable environment with lower interest rates supporting their terminal value. These businesses enjoy network effects and low-cost structures, creating operating leverage. Some well-run Indian platform businesses are showing reduced cash burn and moving toward profitability after spending on customer acquisition over the last decade. | View | |
| 2025 Q4 | Jan 7, 2026 | ITUS Capital | 0.0% | 6.6% | CUB.NS, DRREDDY.NS, EICHERMOT.NS, ERIS.NS, HDFCAMC.NS, HDFCBANK.NS, HDFCLIFE.NS, HINDCOPPER.NS, HINDZINC.NS, ICICIBANK.NS, ICICIGI.NS, NAVINFLUOR.NS, PAYTM.NS, PBFINTECH.NS, PIRAMALP.NS, SBIN.NS, SRF.NS, SWIGGY.NS, TITAN.NS, VEDL.NS | Bottom Up, earnings, growth, healthcare, India, Mining, Multi Cap, selectivity | The fund maintains an overweight position in mining and metals, driven by rising demand for copper in manufacturing and batteries. Performance was largely driven by strong stock selection within the sector, though they remain cautious on incremental additions at current valuations above long-term averages. Despite a challenging year due to tariff-related concerns and adverse headlines from the US, many healthcare businesses continue to invest meaningfully in their core franchises and R&D capabilities. The fund's exposure is aligned toward companies where earnings quality and long-term visibility remain intact. The fund's exposure spans banks, NBFCs, and select non-lending financial institutions. They remain opportunistic in adding risk selectively, guided by valuation discipline and balance sheet strength, with a bottoms-up outlook on lending growth. The fund's consumer exposure is less focused on brands and more on businesses that control distribution channels. They believe this segment has potential to drive incremental growth as consumption normalizes and pricing power becomes more relevant. | View | |
| 2024 Q2 | Jul 27, 2024 | Baron Emerging Markets Fund | 9.0% | 16.2% | 005930.KS, 009540.KS, 0700.HK, 4966.TW, BABA, BDO.PS, BHARTIARTL.NS, BKRKY, CUMMINSIND.NS, INDUSTOWER.NS, PDD, POWERGRID.NS, RELIANCE.NS, RENT3.SA, SRF.NS, SUZ.SA, TRENT.NS, TSM, WEGE3.SA, XP | AI, China, emerging markets, Fed policy, India, semiconductors, Valuations | AI enthusiasm has broadened from GPU/data center arms race to edge AI applications on servers, PCs, and handsets, driving demand for hardware replacement cycles. Many EM companies benefit from this transition, including semiconductor and hardware ecosystem players. The fund sees potential for market leadership changes as AI moves from training to inference phases. | 4966.TW WEGE3.SA SRF.NS CUMMINSIND.NS POWERGRID.NS 009540.KS 0700.HK TSM |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Baron Emerging Markets Fund | SRF Limited | Materials | Specialty Chemicals | Bull | NSE | environmental regulations, India, innovation, Low GWP, R&D, refrigerants, specialty chemicals, Sustainability | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||